1P-AL-LAD
A psychedelic research chemical
| 1P-AL-LAD | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
1P-AL-LAD is a psychedelic research chemical of the lysergamide class. It is structurally related to LSD and is known for its psychoactive effects.
Chemical structure
1P-AL-LAD is a derivative of AL-LAD, which itself is a derivative of lysergic acid diethylamide (LSD). The chemical structure of 1P-AL-LAD includes a propionyl group attached to the nitrogen atom of the indole ring, which distinguishes it from AL-LAD.
Pharmacology
1P-AL-LAD acts as a partial agonist at the 5-HT2A receptor, which is believed to be the primary mechanism responsible for its psychedelic effects. Like other lysergamides, it is thought to affect the serotonin system in the brain, leading to altered perception, mood, and cognition.
Effects
The effects of 1P-AL-LAD are similar to those of LSD and AL-LAD, including visual hallucinations, altered sense of time, and changes in thought patterns. Users may experience enhanced sensory perception and a sense of euphoria. The duration of effects typically lasts between 6 to 10 hours.
Legal status
The legal status of 1P-AL-LAD varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it remains unscheduled. Researchers and users should be aware of the legal implications of possessing or using 1P-AL-LAD in their respective countries.
Safety and toxicity
As a research chemical, the safety profile of 1P-AL-LAD is not well-established. Users should exercise caution and be aware of the potential risks associated with its use. There is limited data on its toxicity, and it is advised to approach its use with the same caution as other psychedelics.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian